FMI research indicates the Global Functional Extracts market grew from USD 65,506.1 million in 2020 at a 5.5% CAGR through 2024. The sector, now valued at USD 86,920.6 million in 2025, is anticipated to expand at a 7.2% CAGR, reaching USD 174,209.0 million by 2035.
The market for producing functional extracts at an industrial scale is in a state of rapid growth. This is because demand is being driven by integrating traditional systems alongside advancements in modern techniques across nutraceuticals, food & beverages, pharmaceuticals and animal nutrition applications. The evolution has moved from mere extraction of plant materials to the extraction of modern herbal extracts that are precise and potent.
The industry is dominated by large corporations that provide bulk quantities of standardized extract as well as regional manufacturers that provide unique high-cost extracts. Preventative medicine being turned into a segment of consumer products and a change in the economic status of many households globally are some of the prominent trends in the industry.
Plant-based extracts are the prominent products in the industry and advancements in plant extraction advancement technology that focus on efficiency while optimizing energy requirements are changing the landscape. The Asia Pacific deals extensively with traditional herbs and essential oils, making this region particularly attractive for integration with extracts. Recently the trend is shifting towards focus on extracts that support the body defense, thus carving a niche in the clinical products space as well.
| Attributes | Description |
|---|---|
| Estimated Global Industry Size (2025E) | USD 86,920.6 Million |
| Projected Global Value (2035F) | USD 174,209.0 Million |
| Value-based CAGR (2025 to 2035) | 7.2% |
Explore FMI!
Book a free demo
The table below presents a comparative assessment of the variation in CAGR over six months for the base year (2024) and current year (2025) for the Global Functional Extracts industry. This analysis reveals crucial shifts in industry performance and indicates revenue realization patterns, thus providing stakeholders with a better vision of the ecosystem growth trajectory over the year. The first half of the year, or H1, spans from January to June. The second half, H2, includes the months from July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 7.9% (2025 to 2034) |
| H2 | 6.5% (2025 to 2034) |
| H1 | 7.7% (2026 to 2035) |
| H2 | 6.8% (2026 to 2035) |
The above table presents the expected CAGR for the Global Functional Extracts industry over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2025 to 2035, the business is predicted to surge at a CAGR of 7.9%, followed by a slightly variable growth rate of 6.5% in the second half (H2) of the same decade. Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to change slightly to 7.7% in the first half and remain relatively moderate at 6.8% in the second half.
Nutraceuticals & Dietary Supplements dominate as applications of functional extracts
The rising trend of using natural products to improve one's well-being has made nutraceuticals and dietary supplements important applications of the functional extracts market. Extracts are also changing the landscape of the supplement industry by targeting an array of problems, ranging from memory improvement to bone joint problems.
The increasing popularity of these products has led retailers to diversify their product ranges and manufacturers to start looking for more and more new ways to combine different functional extracts and make them into new health-oriented products.
There has been a notable trend towards the use of multiple functional extracts rather than single-ingredient extracts in order to provide multiple benefits to consumers. This has also led to more funding in research of extract combinations and finding alternate methods that would increase the effectiveness of the supplements.
Wide usage & familiarity aiding Solvent Extraction in being the prominent extraction method
The solvent extraction method has been widely used in the functional extracts landscape owing to the ease with which isolation of the targeted compounds occurs. Despite being traditional, this technique has been perfected over the years due to extensive industrial safety measures, protocol compliance measures and cost-reduction methods.
The method is popular because it can handle bulk amounts of raw materials and the outcome of extracts are of the same quality. The commercial application of the technique is also increased due to the ease of scaling up the processes and the presence of standardized operating procedures.
Animal feed rising as functional extracts’ application due to demand for functional feed nutrition
The animal feed industry is evolving rapidly due to the usage of extracts due to increasing awareness of livestock health and productivity. These extracts boost the immune system, enhance digestive functionality and improve the general health of the animal without the use of any synthetic supplements. This development resembles the trend of increased consumer desire for naturally raised livestock.
The shift in focus towards functional extracts in animal feed has also been propelled by the growing restrictions on antibiotics in the livestock sector which has made farmers and feed manufacturers to start searching for natural alternatives. Improved feed conversion ratio and the decreased mortality rate of animals that were fed functional extract have also encouraged further expansion of the industry.
Global sales increased at a CAGR of 5.5% from 2020 to 2024. For the next ten years (2025 to 2035), projections are that expenditure on the industry will rise at 7.2% forecast CAGR.
For the past ten years, the growth of the functional extracts industry has been remarkable with it evolving into a well-organized sector. Industrial and commercial demand has increased due to rising consumer awareness of natural health solutions and clean-label products. Traditionally, the market dealt with unrefined medicinal plant extracts which were simple in structure, however, now production of more refined extracts for various industries is taking prominence.
This change began with the development of new extraction methods along with a greater emphasis on the scientific justification of using herbal extracts. Use of preventive treatment & natural drugs has occupied a prominent place in the development of the industry at the global level. The COVID-19 global pandemic also provided many opportunities such as high demand for immune system extracts and a large shift in consumer preferences.
There are many opportunities in the Functional extracts industry due to multiple prominent trends. Factors such as rise in the consumption of functional foods & beverages, demand for natural ingredients in cosmetics and consumer preference for plant-based products will drive growth. New applications in animal feed and the personal care industry are also untapped sectors where growth is likely.
Rapid advancements in extraction techniques, the development of clinical & commercial grade extracts and a greater emphasis on the clinical benefits of extracts will all impact the direction of the growth. The increase in acceptance of traditional medicine in the West and growing interest in researching new plant sources also signal promising future prospects.
Many MNCs prominent in the functional extracts industry, along with many small-scale producers and mid-sized specialized manufacturers contribute to a moderately concentrated industry structure for the Functional Extracts market. Tier-1 companies account for 45% of the functional extracts industry with companies such as Cargill, Kerry Group, International Flavors & Fragrances (IFF) and ADM.
These companies do not maintain their dominance only through their product range, but rather through sophisticated research centers, large databases and inter-corporate structures linking distribution to marketing. Typically focused on low prices, these companies aim to produce large quantities of extracts as well as specialize in designing complex customized products.
The Tier-2 participants make up about 35% of this industry with companies including Martin Bauer Group, Naturex (now part of Givaudan), and Indena. Such companies concentrate on certain categories of extracts or on specific regions where they possess expertise. They are leaders in their specific chosen segments and effectively compete with bigger players in those segments.
20% of this market is composed of Tier-3 players which include many small-scale manufacturing extractors, local extract companies and small shed clinics extract specializing companies. They are the companies that go after narrow niches and concentrate on traditional extracts and specific geographic areas.
This tier includes local herbal extract manufacturers, traditional medicine extract producers and specialized botanical extract companies as well. Though small in individual capacity, these firms are important in improving the diversity of the market.
The following table shows the estimated growth rates of the top five markets. These countries are set to exhibit high consumption, recording high CAGRs through 2035.
| Countries | CAGR 2025 to 2035 |
|---|---|
| USA | 7.3% |
| China | 7.9% |
| Germany | 6.6% |
| Japan | 6.8% |
| India | 8.1% |
Due to strong research facilities along with advanced capabilities of nutraceuticals development, USA has consolidated its position in the functional extracts industry. Academic and private research institutions across the nation are performing studies to support the effectiveness of different extracts as well as focusing on their standardization and Quality control aspects.
The investment made by prominent nutraceutical firms into R&D has made the environment more favorable for extract applications. The FDA has been crucial in defining the quality parameters that have now become the gold standard around the world.
Furthermore, the presence of mature consumers coupled with the country's early adoption of the wellness trend provides a favorable environment for the growth of functional extracts, leading to a constant upgrading of existing products and the emergence of new ones. The industry for Functional Extracts in USA is projected to exhibit a CAGR of 7.3% during the assessment period and revenue from the sales of the product in the country is expected to reach USD 48,778.5 million with a market share of 28% by 2035.
China is a leader in the functional extracts industry, mainly due to the presence of a well-developed ecosystem of herbal products manufacturing factories. The combination of advanced science with the traditional Chinese legacy of herbal medicine has developed an advanced landscape for functional extracts. Manufacturing hubs not only fulfill internal requirements but have also become important processing plants for standardized extracts for overseas demands at reasonable costs, thus leading to industry growth.
This is because of the government making investments in modern facilities for extraction and systems for quality control. Also, China's great agricultural potential and developed supply chains for medicinal plants assure the long-term development of the functional extracts industry. These trends are leading to a projected value of USD 29,615.5 million by 2035 with Functional Extracts demand calculated to rise at a value CAGR of 7.9% during the forecast period (2025 to 2035) with a value share of 17%.
India's functional extracts industry is built upon a merger of traditional knowledge and modern science. The country's many botanical diversities along with its emerging ability to standardize extracts have enabled the manufacturers to come up with various new products for consumers who are looking for age-old solutions with scientific explanations.
In many cases, government initiatives such as AYUSH have promoted traditional medicine systems and the development of medicine procedures in India to modernize traditional medicines. Joint research of universities and industrial enterprises on the use of edging technologies for vetting the old extracts has proved that India is a prominent player in the industry by capturing the wide gap in the industry.
These factors are responsible for the robust projected forecast CAGR of 8.1% from 2025 to 2035, with the country achieving a global value share of 7% in 2035 with a value of USD 12,194.6 million.
| Segment | Plant-based |
|---|---|
| Main Segment | Source Type |
| Value Share (2035) | 62% |
Plant-based extracts have been able to maintain a strong grip in the industry of extracts as the world is undergoing a gradual trend of moving towards plant-based products in place of synthetic options. This is a response to the concerns people have about the environment, ethics and the health benefits that arise from using plant-based products.
Consumers tend to prefer plant-based extracts due to sustainability concerns, while producers tend to like these ingredients as they can be more easily added and accepted into formulations. Many scientific studies also now support the use of plant-based extracts along with assurances of their safety and natural image which has widened their application to more than just food supplements.
This growth has propelled the segment's value to USD 108,009.6 million in 2035 with a market share of 62% and further projections suggest its growth at a CAGR of 6.6%.
| Segment | Immune System Support |
|---|---|
| Main Segment | Functionality |
| Value Share (2035) | 37% |
The COVID-19 pandemic has dramatically changed the views of individual consumers related to their immunity, which has led to a large-scale need for functional extracts with immune-boosting properties. Manufacturers have responded to this demand by increasing the production of newer mixtures that utilize several immune boosters while research organizations have increased their work on herbal extracts with immune-modulating properties.
The pandemic has also quickened the trend of preventive medicine, which has put forward new prospects in product development and increased growth of the immunity-focused portion of the functional extracts industry. Bolstering from these trends, this segment is set to achieve a market share of 37% with a market value of USD 64,457.3 million by 2035 due to growth at a forecast CAGR of 7.5%.
In the Global Functional Extracts Industry, companies are concentrating on strategic activities of acquiring existing competitors and new entrants because of their specialty assets and expertise. Major companies are focusing on vertical integration in order to prevent disruptions in the supply chain, especially those that depend on unique or high-demand plant sources.
Research and development are important to establishing new extraction systems and formulation technologies that provide a competitive advantage. Companies are also working on widening their geographical scope through partnerships and acquisitions, especially in those countries that have a background in traditional medicine systems. Many companies are now adopting sustainability measures in their extraction processes in order to meet the expectations of environmentally conscious consumers.
Research has shown that extracts have been found to improve recovery from exercise and rejuvenate fatigued muscles, so innovation in new extraction methods and new sources of extractsare likely to be major priorities for companies. Consumers are increasingly demanding that brands have proof of their claims and so, companies are also increasingly investing in clinical trials in order to prove the beneficiary effects of functional extracts.
The global market is estimated at a value of USD 86,920.6 million in 2025.
Prominent players in the landscape include Archer Daniels Midland Company (ADM), Cargill Incorporated, Kerry Group, Ingredion Incorporated, Givaudan SA, Ashland Global Holdings Inc, BASF SE, Kemin Industries, Inc, Dupont de Nemours, Inc and Sensient Technologies Corporation.
The Global Industry grew at a Historical CAGR of 5.5% from 2020 to 2024.
The USA sales are projected to hold a revenue share of 28% over the forecast period.
The industry is projected to grow at a forecast CAGR of 7.2% from 2025 to 2035.
As per Source Type, the industry has been categorized into Plant-based, Animal-based, Microbial and Synthetic.
As per Functionality, the industry has been categorized into Immune System Support, Digestive Support, Energy & Metabolism Support, Cardiovascular Support and Stress Management.
As per Extraction Method, the industry has been categorized into Solvent Extraction, Supercritical Fluid Extraction, Steam Distillation, Cold Pressing and Enzymatic Extraction.
As per Application, the industry has been categorized into Food & Beverage, Nutraceuticals, Pharmaceuticals, Cosmetics & Personal Care and Agriculture & Animal Feed.
Industry analysis has been carried out in key countries of North America, Latin America, Western Europe Eastern Europe, Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific and Middle East & Africa.
Functional Extracts Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
